LabCorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.

Bilirubin, Total

CPT: 82247
Print Share

Expected Turnaround Time

Within 1 day

Related Documents

Specimen Requirements


Serum (preferred) or plasma


1 mL

Minimum Volume

0.5 mL (Note: This volume does not allow for repeat testing.)


Red-top tube, gel-barrier tube, or green-top (lithium heparin) tube


Separate serum or plasma from cells within 45 minutes of collection.

Storage Instructions

Room temperature

Stability Requirements



Room temperature

3 days


3 days


14 days

Freeze/thaw cycles

Stable x2

Causes for Rejection

Gross hemolysis; improper labeling; gross lipemia

Test Details


Causes of high bilirubin: Liver disease: hepatitis, cholangitis, cirrhosis, other types of liver disease (including primary or secondary neoplasia); alcoholism (usually with high AST (SGOT), GGT, MCV, or some combination of these findings); biliary obstruction (intrahepatic or extrahepatic); infectious mononucleosis (look also for increased LD (LDH), lymphocytosis); Dubin-Johnson syndrome; Gilbert disease1 (familial hyperbilirubinemia) is encountered as a moderate elevation with otherwise unremarkable chemistries.

Anorexia or prolonged fasting: 36 hours or more may cause moderate rise.

Pernicious anemia, hemolytic anemias, erythroblastosis fetalis, other neonatal jaundice, hematoma, and following a blood transfusion, especially if several units are given in a short time.

Pulmonary embolism and/or infarct, congestive heart failure.

Drugs: A large number of drugs can cause jaundice by in vivo action or by chemistry methodology. Drugs causing cholestasis and/or hepatocellular damage include diphenylhydantoin, azathioprine, phenothiazines, erythromycin, penicillin, sulfonamides, oral contraceptives, anabolic-androgenic steroids, halothane, aminosalicylic acid, isoniazid, methyldopa, indomethacin, pyrazinamide, and others.



Reference Interval

See table.


Range (mg/dL)

Newborns, term, and near term

24 hours


48 hours


72 hours


96 hours to 1 month


Children ≥1 month and adults


Additional Information

Interpretation of increased bilirubin is greatly enhanced by other chemistry results. In acute viral hepatitis with jaundice, for instance, the transaminases ALT (SGPT) and AST (SGOT) are consistently increased, while an isolated elevation of bilirubin is seen in Gilbert disease.1 Obstruction causes increases in bilirubin and alkaline phosphatase greater than and out of proportion to the transaminases.2 Amylase and lipase are useful in differential diagnosis of obstructive jaundice. In intrahepatic cholestasis, the transaminases are not as increased, relative to bilirubin, as they are in hepatitis.3 Work-up of jaundice has been outlined.4,5

Nicotinic acid increases the formation of bilirubin in the spleen, leading to a rise in unconjugated bilirubin. This can be used as a test for Gilbert disease1 in which there is a decreased hepatic clearance of unconjugated bilirubin. Although the indirect bilirubin level is increased in normal controls when nicotinic acid is given, the increase is much greater in patients with Gilbert disease. In the Crigler-Najjar syndrome type I, the unconjugated bilirubin is >20 μg/dL. In type II, the level is <20 μg/dL.


1. Ohkubo H, Okuda K. The nicotinic acid test in constitutional conjugated hyperbilirubinemia and effects of steroids. Hepatology. 1984 Nov-Dec; 4(6):1206-1208. 6500512
2. Scharschmidt BF, Goldberg HI, Schmid R. Current concepts in diagnosis. Approach to the patient with cholestatic jaundice. N Engl J Med. 1983 Jun 23; 308(25):1515-1519. 6855824
3. Goldberg DM, Spooner RJ, Ellis G, Ward AM. Biochemical features of intrahepatic cholestasis. Am J Clin Pathol. 1979 May; 71(5):557-563. 453073
4. Ostrow JD. Jaundice in older children and adults. In: Lundberg GD, ed. Using the Clinical Laboratory in Medical Decision Making. Chicago, Ill: American Society of Clinical Pathologists;1983:41-48.
5. Fischer MG, Gelb AM, Weingarten LA. Cholestatic jaundice in adults. In: Lundberg GD, ed. Using the Clinical Laboratory in Medical Decision Making. Chicago, Ill: American Society of Clinical Pathologists;1983:49-54.


Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
001099 Bilirubin, Total 1975-2 001099 Bilirubin, Total mg/dL 1975-2

For Providers

Please login to order a test

Order a Test

© 2020 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at Additional information regarding LOINC® codes can be found at, including the LOINC Manual, which can be downloaded at